An interventional study of Researcher-Designed Diabetes Self-Management Application in Type 2 Diabetes Mellitus (T2DM) and Self-management, sponsored by Fu Jen Catholic University Hospital. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-31.
Sponsored by Fu Jen Catholic University Hospital · Not applicable, Interventional, and Health services research
This study aims to evaluate the effectiveness of a self-developed diabetes self-management mobile application on disease self-management outcomes among individuals with type 2 diabetes.
Exclusion Criteria:
Participants in the control group will receive routine diabetes care and use the basic functions of the diabetes self-management mobile application. The basic app functions include self-recording of blood glucose, medication, diet, physical activity, and related health information. Participants in this group will not receive additional video-based health education or multidisciplinary team care through the application.
Participants in the intervention group will receive routine diabetes care and access to an enhanced diabetes self-management mobile application, which includes basic self-management recording functions, video-based health education, and multidisciplinary team care to support diabetes self-management.
Behavioral: Researcher-Designed Diabetes Self-Management Application
Participants in the intervention group will receive routine diabetes care and use the enhanced diabetes self-management mobile application. In addition to the basic self-management recording functions, the intervention group will receive video-based health education and multidisciplinary team care through the application. The multidisciplinary team may include healthcare professionals such as physicians, nurses, dietitians, and pharmacists, who provide diabetes-related guidance to support daily self-management, self-efficacy, and metabolic control.
Diabetes management self-efficacy
1. The Chinese version of the Diabetes Management Self-Efficacy Scale(C-DMSES) includes 20 items across four subscales: 1. Nutrition: 9 items 2. Physical activity and weight control: 4 items 3. Medication treatment: 3 items 4. Blood glucose and foot care: 4 items 2. Scores range from 0 to 10. 3. The scale has good reliability, with an overall Cronbach's α of .93. 4. Subscale Cronbach's α values range from .77 to .93. 5. The scale also has good test-retest reliability, with Pearson's r = .86, p \< .01.
Time frame: Baseline, 3 months, and 6 months.
Diabetes self-management obstacles
Diabetes self-management obstacles will be measured using the Chinese Version of the Diabetes Obstacles Questionnaire-Short Form (CDOQ-S). Each item is rated on a 5-point Likert scale, ranging from 1 to 5. The items are negatively scored, and higher scores indicate greater obstacles in diabetes self-management.
Time frame: Baseline, 3 months, and 6 months.
HbA1c
Glycated hemoglobin (HbA1c) will be measured using laboratory blood tests and reported as a percentage (%)
Time frame: Baseline, 3 months, and 6 months
Fasting plasma glucose
Fasting plasma glucose will be measured using laboratory blood tests and reported in milligrams per deciliter (mg/dL).
Time frame: Baseline, 3months, and 6months
Triglycerides
Serum triglyceride levels will be measured using laboratory blood tests and reported in milligrams per deciliter (mg/dL).
Time frame: Baseline, 3months, and 6 months
Total cholesterol
Serum total cholesterol levels will be measured using laboratory blood tests and reported in milligrams per deciliter (mg/dL).
Time frame: Baseline, 3 months, and 6 months.
LDL
Serum low-density lipoprotein cholesterol will be measured using laboratory blood tests and reported in milligrams per deciliter (mg/dL).
Time frame: Baseline, 3 months, and 6 months.
HDL
Serum high-density lipoprotein cholesterol will be measured using laboratory blood tests and reported in milligrams per deciliter (mg/dL).
Time frame: Baseline, 3 months, and 6 months.
No study locations are listed for this record.
This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Fu Jen Catholic University Hospital